Affordable Access

Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma

Publication Date
  • Medicine


A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis. In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma. After controlling for known prognostic factors, we conclude that HRT after melanoma does not adversely affect prognosis.

There are no comments yet on this publication. Be the first to share your thoughts.